What

A Conversation on Oncology: The Evolution Driving Access and Care Delivery

When May 21 2019 1:00 PM - 1:45 PM (EDT)

The oncology landscape continues to see significant changes as public focus on costs is amplified by drug pricing reforms, providers take on more financial risk, and clinical advancements outpace existing regulatory and reimbursement mechanisms. As provider participation in initiatives such as the Oncology Care Model (OCM) spurs transformation in oncology care, life science companies need to seek new ways to demonstrate value. It is critical to understand how alignment to new reforms and initiatives could impact providers and patients from an access, quality, and affordability perspective. As we prepare for ASCO 2019, join us as Avalere experts unpack the complex dynamics stakeholders must consider spanning policy, market access and reimbursement, and regulatory implications.

* *
*
*
*
Industry*
Business Unit*